GW501516, also known as Cardarine, is a PPARδ receptor agonist discovered in the 1990s. It was originally developed to treat obesity, diabetes and cardiovascular disease. But as research continues to deepen, GW501516（Cardarine） has gradually become one of the most popular fats reducing SARMs. It is a selective agonist of the PPARδ receptor with high …